In PD and other neuroinflammatory conditions, reactive astrocytes exhibit reduced EAAT2 expression or function, impairing glutamate clearance and exacerbating excitotoxic injury [21,35,36,37,38,39,40,41]. The gene discussed is SLC1A2; the disease is Parkinson disease.